Noteworthily, the tumor cured mice treated with NCPA were shown a significant increment of the whole CD4+ and CD8+ T cells as well as central memory CD4+ and CD8+ T cells in both spleen and TDLN, demonstrating the NCPA could potentially elicit immune memory to prevent tumor recurrence. Here, CD8A is linked to neoplasm.